Myocardial no-reflow in humans | Journal of the American College of Cardiology | 2009 | 569 |
Elevated levels of interleukin-6 in unstable angina | Circulation | 1996 | 459 |
Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability | Circulation | 1999 | 455 |
Coronary microvascular dysfunction: an update | European Heart Journal | 2014 | 417 |
Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events | Circulation | 1999 | 410 |
Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy | New England Journal of Medicine | 2001 | 282 |
Association of virulent Helicobacter pylori strains with ischemic heart disease | Circulation | 1998 | 255 |
International standardization of diagnostic criteria for microvascular angina | International Journal of Cardiology | 2018 | 254 |
Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients | Journal of the American College of Cardiology | 1999 | 252 |
Inflammatory cytokines in atherosclerosis: current therapeutic approaches | European Heart Journal | 2016 | 234 |
International standardization of diagnostic criteria for vasospastic angina | European Heart Journal | 2017 | 216 |
Classification of coronary artery bifurcation lesions and treatments: time for a consensus! | Catheterization and Cardiovascular Interventions | 2008 | 210 |
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function | European Heart Journal | 2005 | 207 |
Coronary microvascular obstruction in acute myocardial infarction | European Heart Journal | 2016 | 201 |
Sex-related differences in myocardial remodeling | Journal of the American College of Cardiology | 2010 | 199 |
Acute myocardial infarction with no obstructive coronary atherosclerosis: mechanisms and management | European Heart Journal | 2015 | 194 |
Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes | Mediators of Inflammation | 2008 | 193 |
Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in Apical Ballooning or Tako-Tsubo Syndrome | European Heart Journal | 2010 | 187 |
High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study | Circulation | 2010 | 170 |
Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound | Circulation | 2006 | 169 |
The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study | Journal of the American College of Cardiology | 2008 | 167 |
Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome | European Heart Journal | 2015 | 161 |
Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure | Journal of the American College of Cardiology | 2003 | 156 |
Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling | Journal of Cellular Physiology | 2002 | 149 |
Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function | European Heart Journal | 2007 | 144 |